ArticleTherapeutics and clinical risk management2019
Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study.
Abstract read
In one paragraph
Article in Therapeutics and clinical risk management, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- CSsingle: a unified tool for robust decomposition of bulk and spatial transcriptomic data across diverse single-cell references.Nucleic acids research · 2026Article
- The Neutrophil/Lymphocyte Ratio Was Identified as a Marker of Severe Influenza During the 2024-2025 Outbreak in France.Infectious disease reports · 2025Article
- A simple, rapid, and cost-effective model for predicting critical influenza a infection in children: a multicentre, retrospective cohort study.BMC pediatrics · 2025Article
- Article
- Neutrophil-to-lymphocyte ratio as a prognostic indicator in COVID-19: Evidence from a northern tanzanian cohort.PloS one · 2025Article
- Comparative analysis of adenovirus and rotavirus gastroenteritis: insights into inflammatory response and temporal variations.Frontiers in pediatrics · 2025Article
- Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza.The Journal of infectious diseases · 2024Article
- Article
- Human placental hematopoietic stem cell derived natural killer cells (CYNK-001) mediate protection against influenza a viral infection.Human vaccines & immunotherapeutics · 2022Article
- Using neutrophil to lymphocyte ratio to predict discharge among geriatric patients with influenza infection in emergency department.Medicine · 2022Article
- A dynamic model for individualized prognosis prediction in patients with avian influenza A H7N9.Annals of translational medicine · 2022Article
- Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting influenza susceptibility.Frontiers in microbiology · 2022Article
- Comparative study of hematological and radiological feature of severe/critically ill patients with COVID-19, influenza A H7N9, and H1N1 pneumonia.Journal of clinical laboratory analysis · 2021Article
- Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection.Scientific reports · 2021Article
- The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?Cytokine · 2021Review
- Contact-dependent inhibition of HIV-1 replication inCell reports. Medicine · 2021Article
- High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.Cellular and molecular life sciences : CMLS · 2021Observational
- Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity.International immunopharmacology · 2021Article
- COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19.PloS one · 2021Article
- The Value of Combined Serum Amyloid A Protein and Neutrophil-to-Lymphocyte Ratio Testing in the Diagnosis and Treatment of Influenza A in Children.International journal of general medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Yan ZhangThe State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
Pengfei ZouDepartment of Infectious Disease, Shulan Hospital, Hangzhou, Zhejiang Province, People's Republic of China.
Hainv GaoDepartment of Infectious Disease, Shulan Hospital, Hangzhou, Zhejiang Province, People's Republic of China.
Meifang YangThe State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
Ping YiThe State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
Jianhe GanDepartment of Infectious Disease, The First Affiliated Hospital, Medical College of Soochow University, Suzhou, Jiangsu Province, People's Republic of China.
Yinzhong ShenDepartment of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
Weihong WangDepartment of Infectious Disease, Central Hospital of Huzhou, Zhejiang, People's Republic of China.
Wenhong ZhangDepartment of Infectious Disease, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Jun LiDepartment of Infectious Disease, Jiangsu Province People's Hospital, Jiangsu, People's Republic of China.
Peng LiuDepartment of Infectious Disease, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Lanjuan LiThe State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AIV-H7N9biomarkerinfluenza ANLR (neutrophil-to-lymphocyte ratio)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.